BIOETON POLSKA
BUKOWIŃSKA 22B, 02-703 WARSZAWA
TAX ID5213641027
Rate company:
BIOETON POLSKA
TAX ID5213641027
Share capital200,000.00 zł
No opinion.   Add your first review

address

BUKOWIŃSKA 22B, 02-703 WARSZAWA

Register Data

Full name

ADVANCED BIOCOMPONENTS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Copy
uses securityreCAPTCHA

Legal address

UL. CHOCIMSKA 4, 00-791 WARSZAWA

NIP

5213641027
Copy

REGON

146414961
Copy

KRS

0000862859
Copy

Legal form

limited liability company

ALEO.com Registration Date

2013-12-03

Register Address

UL. CHOCIMSKA 4, 00-791 WARSZAWA

Date of registration in KRS

2020-10-01

Date of commencement of economic activity

2020-10-01

Act signature

RDF/683502/24/198

Pkd codes

72.11.Z - Research and experimental development on biotechnology

19.20.Z - Manufacture and processing ofrefind petroleum products

46.19.Z - Agents involved in the sale of a variety of goods

46.71.Z - Wholesale of fuels and related products

46.75.Z - Wholesale of chemical products

46.76.Z - Wholesale of other intermediate products

64.19.Z - Other monetary intermediation

64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified

70.22.Z - Business and other management consultancy activities

72.19.Z - Other research and experimental development on natural sciences and engineering


Active
Vat list bank account(s)

Company authorities

representation authorityMANAGEMENT
supervisory authorityboard of directors
representation type
DO SKŁADANIA OŚWIADCZEŃ WOLI I PODPISYWANIA W IMIENIU SPÓŁKI UPOWAŻNIENI SĄ: - PREZES ZARZĄDU - SAMODZIELNIE, - DWAJ CZŁONKOWIE ZARZĄDU DZIAŁAJĄCY ŁĄCZNIE LUB, - CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM.
MANAGEMENT
Edmund Puzio
Chairman Of The Board, 74 years old
shareholders
BIOETON DEUTSCHLAND GMBH

100% 4000 udziałów o łącznej wartości 200.000 złotych

Financial data

Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
2020 2021 2022
M PLN
M PLN
M PLN
%
Profit (loss) on sale Indicator description
0,6
0,3
-0
-111,6
Gross profit (loss) Indicator description
0,6
0,3
-0
-112,4
EBITDA Indicator description
0,6
0,3
-0
-109,2
Short time liabilities Indicator description
0
0
0,1
-∞
Other operating costs Indicator description
0
0
0
-92,1
Equity capital Indicator description
0,6
0,9
0,8
-5,8
Operating profit (EBIT) Indicator description
0,6
0,3
-0
-111,9
Assets Indicator description
0,6
1,1
1
-10,4
Net profit (loss) Indicator description
0,6
0,3
-0,1
-115,2
Cash Indicator description
0
0,3
0,2
-38,9
Net income from sale Indicator description
1,2
1,1
1
-12,2
Liabilities and provisions for liabilities Indicator description
0
0
0,1
-∞
Working assets Indicator description
0,6
1,1
1
-12,6
Other income costs Indicator description
0
0
0
-93,1
Depreciation Indicator description
0
0
0
59,8
%
%
%
p.p.
Profitability of capital Indicator description
99,9
38,2
-6,2
-44,4
Equity capital to total assets Indicator description
93,5
80,9
85
4,1
Gross profit margin Indicator description
46,6
30,3
-4,3
-34,6
EBITDA Margin Indicator description
46,7
30,9
-3,3
-34,2
Days
Days
Days
Days
Short term commitment turnover cycle Indicator description
12
0
55
55
Current financial liquidity indicator Indicator description
15.08029842376709
6.471209526062012
-8,6
Net dept to EBITDA Indicator description
-0.051776181906461716
-0.4114833474159241
3.8081724643707275
4,2
See more

Financial statements

01-01-2022 - 31-12-2022
Annual financial report
Download xades

01-01-2022 - 31-12-2022
Annual financial report
Download pdf

01-01-2022 - 31-12-2022
Resolution or decision approving the annual financial statements
Download pdf
Show more (1)
uses security  reCAPTCHA

Opinions

Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane

0/ 5.0
How do you rate this company?
Your opinion matters to us.

Companies registered in the same sector